Answers are grounded in this paper and cite their sources.
Background Neuro-ophthalmic findings occur across autoimmune encephalitis syndromes but have not been synthesized at the patient level. We characterized reported afferent and efferent phenotypes, separated direct inflammatory from secondary or uncertain findings, and explored their capture by the Antibody Prevalence in Epilepsy and Encephalopathy (APE2) score. Methods PubMed, Web of Science, Scopus, and Cochrane were searched to April 2026 for human studies reporting neuro-ophthalmic findings in antibody-defined or criteria-based autoimmune encephalitis. Individually described patients were characterized by phenotype, laterality, severity, objective testing, timing, treatment, and outcome. Findings were graded as direct inflammatory involvement (high or moderate confidence), secondary, or uncertain. Exploratory APE2 scores were assigned retrospectively. Results Of 1,562 records, 43 studies were included (28 case reports, 9 case series, 6 cohort or cross-sectional studies). Thirty-seven individually described patients contributed 43 observations (19 afferent, 24 efferent). Afferent observations were optic neuritis (6), bilateral optic disc edema (9; opening pressure normal in 4, raised in 2, not reported in 3), retinal or uveal inflammation (2), and other visual disturbance (2). Efferent observations were nystagmus (9), gaze palsy or deviation (4), ocular motor nerve or neuromuscular-type deficits (4), saccadic intrusions or pursuit abnormalities (3), and diplopia without a documented deficit (4). Eight observations were graded as direct involvement with high confidence, 21 with moderate confidence, 3 secondary, and 11 uncertain. Among 15 patients with optic nerve or disc involvement, optical coherence tomography (OCT), visual evoked potentials, and perimetry were reported in only 6, 3, and 3. Findings were inaugural in 14 patients. Of 32 patients scored, 19 had an APE2 score of at least 4, 6 remained below 4 under maximal assumptions, and 7 were indeterminate. Conclusions Reported neuro-ophthalmic involvement in autoimmune encephalitis ranges from objectively documented inflammatory optic neuropathy and papillitis to secondary papilledema and symptom-level descriptions. Opening pressure, aquaporin-4 and MOG antibody testing, OCT, perimetry, and examination-based ocular motor localization should accompany such findings. A low APE2 score should not by itself deter antibody testing when the neuro-ophthalmic phenotype is suggestive. These outcome-selected data do not establish frequency or prognosis.
No takes yet. Share an insight, caveat, or question.
Bonajmah et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: